BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21790895)

  • 21. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
    Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F
    Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue.
    Wołowiec D; Benchaib M; Pernas P; Deviller P; Souchier C; Rimokh R; Felman P; Bryon PA; Ffrench M
    Leukemia; 1995 Aug; 9(8):1382-8. PubMed ID: 7643628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of cyclin D2 in chronic B-cell malignancies.
    Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
    Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax.
    Iwanaga R; Ozono E; Fujisawa J; Ikeda MA; Okamura N; Huang Y; Ohtani K
    Oncogene; 2008 Sep; 27(42):5635-42. PubMed ID: 18504428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
    Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
    Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma].
    Qi RJ; Zhang PH; Qiu LG; Fang LH; Yang QY; Sun FJ; Chen HS
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):329-32. PubMed ID: 19575876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
    Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL.
    Halina A; Artur P; Barbara MK; Joanna S; Anna D
    Folia Histochem Cytobiol; 2010 Dec; 48(4):534-41. PubMed ID: 21478095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
    Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
    Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia.
    Teixeira Mendes LS; Peters N; Attygalle AD; Wotherspoon A
    J Clin Pathol; 2017 Oct; 70(10):899-902. PubMed ID: 28408436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Wu J; Zhang Y; Sun L; Zhai Q
    Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia.
    Williams ME; Whitefield M; Swerdlow SH
    Ann Oncol; 1997; 8 Suppl 2():71-3. PubMed ID: 9209645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.
    Saborit-Villarroya I; Vaisitti T; Rossi D; D'Arena G; Gaidano G; Malavasi F; Deaglio S
    Leukemia; 2011 Mar; 25(3):479-88. PubMed ID: 21212793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
    Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
    Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective usage of D-type cyclins in lymphoid malignancies.
    Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
    Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
    Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
    Leukemia; 2009 Nov; 23(11):2018-26. PubMed ID: 19641524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.